APLM - MCAP CO - Apollomics, Inc.

This daily price chart for Apollomics, Inc. (APLM) illustrates the price action of an asset with a market capitalization of 0.07. Current revenue is driven by the sale of a lung cancer drug in China, while the costs associated with US research are already priced in. Apollomics, Inc. (APLM) focuses on precision therapy, attracting global experts through large-scale trials. The team's high intellectual capital is supported by significant R&D investments and stock option programs.

Market capitalization reflects the aggregate value of all outstanding shares, defining the current scale of the business in the eyes of investors. The price action on the Apollomics, Inc. (APLM) capitalization chart allows for the tracking of real-time capital allocation. This metric is calculated by multiplying the current market price of a single security by the total number of shares outstanding. Growth in this metric confirms market confidence in the commercialization of Apollomics, Inc. (APLM) oncology drugs, which is critical for assessing the expansion of targeted therapies across US and Asian markets.